Inventor · disambiguated record
Tomoko Matsushima
Also filed as: MATSUSHIMA TOMOKO
10 granted patents·1 pending application·4 citations·filing 2004–2012
77Inventor score
Top patents by PatentIndex Score
11 records- 0170US8021831B2Taxane chemosensitivity prediction testUNIV TEXAS·Filed 2004·Granted Sep 20, 2011·3 cites·13 claims
- 0260US7957910B2Method for predicting effectiveness of chemotherapySYSMEX CORP·Filed 2006·Granted Jun 7, 2011·1 cites·9 claims
- 0348US8014960B2Method of supporting a diagnosis of a risk of cancer recurrence, and a device of supporting a diagnosis of a risk of cancer recurrenceSYSMEX CORP·Filed 2008·Granted Sep 6, 2011·0 cites·20 claims
- 0447US7682785B2Method for predicting effectiveness of chemotherapy using anticancer agentSYSMEX CORP·Filed 2006·Granted Mar 23, 2010·0 cites·19 claims
- 0545US8131520B2Cancer diagnostic deviceISHIHARA HIDEKI·Filed 2008·Granted Mar 6, 2012·0 cites·20 claims
- 0644US8041514B2Method for judging feature of malignant tumorSYSMEX CORP·Filed 2007·Granted Oct 18, 2011·0 cites·11 claims
- 0744US2006292645A1Method and reagent for measuring kinase activitySYSMEX CORP·Filed 2006·Application pending·0 cites
- 0843US8160821B2Method for supporting a diagnosis of an effect of a treatment by using anthracycline anticancer drugs and a device for supporting a diagnosis for an effect of a treatment by using anthracycline anticancer drugsSHIBAYAMA MASAKI·Filed 2008·Granted Apr 17, 2012·0 cites·14 claims
- 0941US8921114B2Diagnosis support system for cancer, diagnosis support information providing method for cancer, and computer program productISHIHARA HIDEKI·Filed 2008·Granted Dec 30, 2014·0 cites·25 claims
- 1038US8921057B2Method of assessing properties of mammalian cells, and method of diagnosing cancer using the sameISHIHARA HIDEKI·Filed 2005·Granted Dec 30, 2014·0 cites·7 claims
- 1137US9146239B2Method of judging risk of cancer recurrence and computer programSYSMEX CORP·Filed 2012·Granted Sep 29, 2015·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →